IBD (MIAH + calprotectine test)

How does it work?

Inflammatory bowel disease (IBD) is a chronic, progressive, and disabling inflammatory disease of the gastrointestinal tract and encompasses Ulcerative Colitis and Crohn’s Disease. These diseases cannot be cured with medication but medication can suppress symptoms and inflammation to improve the patient’s quality of life and to prevent complications.

Tight control of IBD disease activity is essential but comes at a high cost because treatments are time consuming for both IBD patients and health care professionals.

To improve disease control and empower patients, eHealth technologies have been developed.Studies with IBD patients have shown that telemonitoring significantly reduces the number of hospital visits and admissions, and cuts the IBD burden on health care resources.

Luscii IBD telemonitoring is a tailor-made program that educates and empowers patients. The Luscii app contains the MIAH questionnaire and a home faecal calprotectin test. The outcome reports the patient’s disease status at that specific time and enables the health care professional to customize care and give virtual follow-up.